Cerevel Therapeutics Holdings, Inc. (CERE)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.84B |
| Enterprise value | 3.32B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 7.37 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -9.15 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.53 |
| 52-week change 3 | -27.87% |
| S&P500 52-week change 3 | -10.17% |
| 52-week high 3 | 41.46 |
| 52-week low 3 | 19.86 |
| 50-day moving average 3 | 30.14 |
| 200-day moving average 3 | 29.08 |
Share statistics
| Avg vol (3-month) 3 | 625.9k |
| Avg vol (10-day) 3 | 850.11k |
| Shares outstanding 5 | 156.66M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 68.58M |
| % held by insiders 1 | 17.56% |
| % held by institutions 1 | 86.29% |
| Shares short (27 Feb 2023) 4 | 4.82M |
| Short ratio (27 Feb 2023) 4 | 7.17 |
| Short % of float (27 Feb 2023) 4 | 10.32% |
| Short % of shares outstanding (27 Feb 2023) 4 | 3.08% |
| Shares short (prior month 30 Jan 2023) 4 | 5.7M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 30 Dec 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -26.94% |
| Return on equity (ttm) | -63.91% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -362.94M |
| Net income avi to common (ttm) | -351.51M |
| Diluted EPS (ttm) | -2.26 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 892.03M |
| Total cash per share (mrq) | 5.69 |
| Total debt (mrq) | 426.92M |
| Total debt/equity (mrq) | 81.90 |
| Current ratio (mrq) | 12.48 |
| Book value per share (mrq) | 3.33 |
Cash flow statement
| Operating cash flow (ttm) | -293.19M |
| Levered free cash flow (ttm) | -164.35M |
© 2023 Yahoo. All rights reserved.
